Ru Cheng

12.1k total citations · 3 hit papers
123 papers, 10.7k citations indexed

About

Ru Cheng is a scholar working on Biomaterials, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Ru Cheng has authored 123 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Biomaterials, 60 papers in Molecular Biology and 52 papers in Biomedical Engineering. Recurrent topics in Ru Cheng's work include Nanoparticle-Based Drug Delivery (63 papers), RNA Interference and Gene Delivery (32 papers) and Nanoplatforms for cancer theranostics (29 papers). Ru Cheng is often cited by papers focused on Nanoparticle-Based Drug Delivery (63 papers), RNA Interference and Gene Delivery (32 papers) and Nanoplatforms for cancer theranostics (29 papers). Ru Cheng collaborates with scholars based in China, Netherlands and France. Ru Cheng's co-authors include Zhiyuan Zhong, Fenghua Meng, Chao Deng, Jan Feijén, Harm‐Anton Klok, Huanli Sun, Haiyan Liu, Fang Feng, Yinan Zhong and Jian Zhang and has published in prestigious journals such as Advanced Materials, Angewandte Chemie International Edition and Accounts of Chemical Research.

In The Last Decade

Ru Cheng

121 papers receiving 10.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Glutathione-responsive nano-vehicles as a promising platform for targeted intracellular drug and gene delivery

2011 1.2k citations Ru Cheng, Fenghua Meng et al. Journal of Controlled Release profile →
Dual and multi-stimuli responsive polymeric nanoparticles for programmed site-specific drug delivery

2013 1.1k citations Ru Cheng, Fenghua Meng et al. Biomaterials profile →
Biodegradable polymeric micelles for targeted and controlled anticancer drug delivery: Promises, progress and prospects

2012 501 citations Chao Deng, Ru Cheng et al. Nano Today profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ru Cheng China	50	7.1k	4.7k	3.7k	2.7k	1.7k	123	10.7k
Eun Seong Lee South Korea	50	5.8k 0.8×	4.6k 1.0×	3.5k 0.9×	1.5k 0.6×	1.0k 0.6×	217	10.5k
Xiqun Jiang China	63	4.9k 0.7×	5.4k 1.2×	2.9k 0.8×	1.7k 0.7×	922 0.6×	248	11.8k
Simona Mura France	33	4.7k 0.7×	4.3k 0.9×	2.8k 0.8×	1.5k 0.6×	788 0.5×	75	9.7k
Horacio Cabral Japan	57	7.4k 1.1×	6.0k 1.3×	5.7k 1.5×	1.9k 0.7×	1.1k 0.6×	184	13.9k
Jin‐Zhi Du China	42	5.0k 0.7×	4.7k 1.0×	3.3k 0.9×	1.2k 0.5×	905 0.5×	97	8.9k
Shigeto Fukushima Japan	39	3.9k 0.6×	2.2k 0.5×	3.7k 1.0×	1.7k 0.7×	970 0.6×	60	7.5k
Tatiana K. Bronich United States	52	3.6k 0.5×	1.7k 0.4×	2.6k 0.7×	3.0k 1.1×	1.2k 0.7×	125	8.7k
Sang Cheon Lee South Korea	46	3.7k 0.5×	3.1k 0.7×	1.6k 0.4×	1.4k 0.5×	934 0.6×	120	7.3k
Zhishen Ge China	56	3.7k 0.5×	3.6k 0.8×	1.9k 0.5×	2.9k 1.1×	1.4k 0.8×	135	8.4k
Kanjiro Miyata Japan	58	4.2k 0.6×	2.7k 0.6×	7.2k 1.9×	1.8k 0.7×	1.1k 0.7×	152	11.0k

Countries citing papers authored by Ru Cheng

Since Specialization

Citations

This map shows the geographic impact of Ru Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ru Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ru Cheng more than expected).

Fields of papers citing papers by Ru Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ru Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ru Cheng. The network helps show where Ru Cheng may publish in the future.

Co-authorship network of co-authors of Ru Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ru Cheng. A scholar is included among the top collaborators of Ru Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ru Cheng. Ru Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Xiaotong, Ru Cheng, Yu-Chun Wu, et al.. (2025). Lymph node targeting nanomedicines for tumor immunotherapy. Biomaterials. 327. 123735–123735.

Jiang, Jingjing, et al.. (2024). Multi-omics analysis reveals mechanism of Schisandra chinensis lignans and acteoside on EMT in hepatoma cells via ERK1/2 pathway. Functional & Integrative Genomics. 24(3). 112–112. 6 indexed citations

Li, Chenming, Jiaying Li, Songsong Zhao, et al.. (2023). Exogenous CD38 upregulation enables high-efficacy dually cascade targeted molecular therapy of leukemia. Nano Today. 50. 101872–101872. 9 indexed citations

Cheng, Ru, Min Huang, Qian Li, et al.. (2023). Highly sensitive plasmonic biosensor for hepatitis B virus DNA based on the surface etching of the active helical gold nanorods. Chemical Engineering Journal. 468. 143627–143627. 17 indexed citations

Qin, Yuan, Daoyang Fan, Yifan Zhang, et al.. (2023). CD38-selective immuno-nano-DM1 conjugates for depleting multiple myeloma. Biomaterials Science. 11(14). 4985–4994. 2 indexed citations

Zhang, Qiang, Ru Cheng, Zhu Fu, et al.. (2021). Plasmonic biosensor for the highly sensitive detection of microRNA-21 via the chemical etching of gold nanorods under a dark-field microscope. Biosensors and Bioelectronics. 201. 113942–113942. 26 indexed citations

Gu, Xiaolei, Yaohua Wei, Huanli Sun, et al.. (2019). cRGD-decorated biodegradable polytyrosine nanoparticles for robust encapsulation and targeted delivery of doxorubicin to colorectal cancer in vivo. Journal of Controlled Release. 301. 110–118. 83 indexed citations

Qiu, Min, Huanli Sun, Fenghua Meng, et al.. (2018). Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo. Journal of Controlled Release. 272. 107–113. 43 indexed citations

Zhong, Ping, Min Qiu, Jian Zhang, et al.. (2017). cRGD-installed docetaxel-loaded mertansine prodrug micelles: redox-triggered ratiometric dual drug release and targeted synergistic treatment of B16F10 melanoma. Nanotechnology. 28(29). 295103–295103. 26 indexed citations

10.

Zhu, Yaqin, Xiuxiu Wang, Jing Chen, et al.. (2016). Bioresponsive and fluorescent hyaluronic acid-iodixanol nanogels for targeted X-ray computed tomography imaging and chemotherapy of breast tumors. Journal of Controlled Release. 244(Pt B). 229–239. 46 indexed citations

11.

Zhong, Yinan, Chao Wang, Ru Cheng, et al.. (2014). cRGD-directed, NIR-responsive and robust AuNR/PEG–PCL hybrid nanoparticles for targeted chemotherapy of glioblastoma in vivo. Journal of Controlled Release. 195. 63–71. 79 indexed citations

12.

Sun, Huanli, Fenghua Meng, Ru Cheng, Chao Deng, & Zhiyuan Zhong. (2013). Reduction-Responsive Polymeric Micelles and Vesicles for Triggered Intracellular Drug Release. Antioxidants and Redox Signaling. 21(5). 755–767. 68 indexed citations

13.

Chen, Wei, Ping Zhong, Fenghua Meng, et al.. (2013). Redox and pH-responsive degradable micelles for dually activated intracellular anticancer drug release. Journal of Controlled Release. 169(3). 171–179. 324 indexed citations

14.

Wu, Liangliang, Yan Zou, Chao Deng, et al.. (2013). Intracellular release of doxorubicin from core-crosslinked polypeptide micelles triggered by both pH and reduction conditions. Biomaterials. 34(21). 5262–5272. 172 indexed citations

15.

Sun, Huanli, Fenghua Meng, Ru Cheng, Chao Deng, & Zhiyuan Zhong. (2013). Reduction-sensitive degradable micellar nanoparticles as smart and intuitive delivery systems for cancer chemotherapy. Expert Opinion on Drug Delivery. 10(8). 1109–1122. 67 indexed citations

16.

Wu, Yali, Wei Chen, Fenghua Meng, et al.. (2012). Core-crosslinked pH-sensitive degradable micelles: A promising approach to resolve the extracellular stability versus intracellular drug release dilemma. Journal of Controlled Release. 164(3). 338–345. 157 indexed citations

17.

Li, Yuling, Li Zhu, Ru Cheng, et al.. (2009). Reversibly Stabilized Multifunctional Dextran Nanoparticles Efficiently Deliver Doxorubicin into the Nuclei of Cancer Cells. Angewandte Chemie International Edition. 48(52). 9914–9918. 405 indexed citations

18.

Xu, Yanmin, Fenghua Meng, Ru Cheng, & Zhiyuan Zhong. (2009). Reduction‐Sensitive Reversibly Crosslinked Biodegradable Micelles for Triggered Release of Doxorubicin. Macromolecular Bioscience. 9(12). 1254–1261. 89 indexed citations

19.

Sun, Huanli, Bingnan Guo, Ru Cheng, et al.. (2009). Biodegradable micelles with sheddable poly(ethylene glycol) shells for triggered intracellular release of doxorubicin. Biomaterials. 30(31). 6358–6366. 394 indexed citations

20.

Srivastava, Indresh K., Elaine Kan, Yide Sun, et al.. (2007). Comparative evaluation of trimeric envelope glycoproteins derived from subtype C and B HIV-1 R5 isolates. Virology. 372(2). 273–290. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact